APA (7th ed.) Citation

D, P., E, B., G, M., M, Z., L, A., R, H., . . . F, T. (2024). Negative effect of treatment with mGluR5 negative allosteric modulator AFQ056 on blood biomarkers in young individuals with Fragile X syndrome. SAGE open medicine, 12, 20503121241282401. https://doi.org/10.1177/20503121241282401

Chicago Style (17th ed.) Citation

D, Protic, et al. "Negative Effect of Treatment with MGluR5 Negative Allosteric Modulator AFQ056 on Blood Biomarkers in Young Individuals with Fragile X Syndrome." SAGE Open Medicine 12 (2024): 20503121241282401. https://doi.org/10.1177/20503121241282401.

MLA (9th ed.) Citation

D, Protic, et al. "Negative Effect of Treatment with MGluR5 Negative Allosteric Modulator AFQ056 on Blood Biomarkers in Young Individuals with Fragile X Syndrome." SAGE Open Medicine, vol. 12, 2024, p. 20503121241282401, https://doi.org/10.1177/20503121241282401.